Difficulty: Medium
Average Score: 82%
Practice
A woman who takes highly active antiretroviral therapy (HAART) for HIV/AIDS has become pregnant. What effect will the woman's pregnancy have on her drug regimen?
Correct answer
C
Rationale
Choice A is incorrect because discontinuing HAART during pregnancy can actually increase the risk of HIV transmission from mother to child. HAART is crucial in reducing the viral load in pregnant women with HIV, therefore discontinuation would be detrimental.
Choice B is incorrect because increasing the dosage of HAART during pregnancy is not a standard practice. The goal is to maintain the viral load at a low level to reduce the risk of transmission to the baby, but this can usually be achieved with the standard regimen without the need for dosage adjustments.
Choice D is incorrect because not all components of HAART are contraindicated during pregnancy. While some drugs may need to be switched due to potential teratogenic effects, many of the medications used in HAART are safe to use during pregnancy and can be continued without any changes.
The correct answer, choice C, is supported by guidelines from organizations such as the World Health Organization and the Centers for Disease Control and Prevention, which recommend that pregnant women with HIV continue their HAART regimen unchanged if it is effective and well-tolerated. This helps to control the viral load, reduce the risk of transmission to the baby, and maintain the health of the mother.
Choice B is incorrect because increasing the dosage of HAART during pregnancy is not a standard practice. The goal is to maintain the viral load at a low level to reduce the risk of transmission to the baby, but this can usually be achieved with the standard regimen without the need for dosage adjustments.
Choice D is incorrect because not all components of HAART are contraindicated during pregnancy. While some drugs may need to be switched due to potential teratogenic effects, many of the medications used in HAART are safe to use during pregnancy and can be continued without any changes.
The correct answer, choice C, is supported by guidelines from organizations such as the World Health Organization and the Centers for Disease Control and Prevention, which recommend that pregnant women with HIV continue their HAART regimen unchanged if it is effective and well-tolerated. This helps to control the viral load, reduce the risk of transmission to the baby, and maintain the health of the mother.